A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1992
12/30/1992	EP0520372A1 Inositol phosphate analogues as calcium-antagonistic substances
12/30/1992	EP0519996A1 Imidazoles
12/30/1992	EP0208785B1 Fibrinophilic urokinase complex and process for its preparation
12/30/1992	CN1067431A Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them
12/30/1992	CN1067427A Pyrazolopyridine compound and processes for preparation thereof
12/29/1992	US5175380 Process for removing impurities from perfluorinated alkyl bromides or alkylene dibromides
12/29/1992	US5175105 Process for the production of urokinase using saccharomyes cerevisiae
12/29/1992	CA1312084C 1,3-dioxan-5-xl alkanoic acid derivatives
12/29/1992	CA1312077C Process for preparing 1,5-benzothiazepine derivatives
12/29/1992	CA1312011C Concentrated stable fluorochemical aqueous emulsions
12/29/1992	CA1312010C Stable fluorochemical aqueous emulsions
12/27/1992	CA2072303A1 Inositol phosphate analogues as calcium-antagonistic substances
12/23/1992	WO1992022646A1 Production of human hemoglobin in transgenic pigs
12/23/1992	WO1992022202A1 Thrombolytic and perfluorochemical treatment for myocardial infraction
12/23/1992	WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
12/23/1992	EP0519903A1 Drug containing activated protein C
12/23/1992	EP0519902A1 Method of preparing activated protein C
12/23/1992	EP0519900A1 Pharmaceutical preparation containing a thrombolytically active substance and Protein C
12/23/1992	EP0518933A1 Leukaemia inhibitory factor
12/23/1992	EP0241533B1 Rapid acting intravenous emulsions of omega-3 fatty acid esters
12/23/1992	CN1067249A Amidinophenylalanine derivatives and process for preparing same and use
12/23/1992	CN1067244A Pyrrolidones
12/23/1992	CA2111348A1 Production of human hemoglobin in transgenic pigs
12/22/1992	US5173502 For treating depression, hypertension, parkinson*s disease, asthma, convulasions, platelet aggregation of metabolic disorders
12/19/1992	CA2071456A1 Method of treating adult t-cell leukemia/lymphoma
12/16/1992	EP0518819A2 Amidino compounds, their manufacture and use as medicament
12/16/1992	EP0518818A2 Arylethers, their manufacture and use as medicament
12/16/1992	EP0518798A2 Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders
12/16/1992	EP0518652A1 Compounds and methods for treatment of thromboembolic disorders
12/16/1992	EP0518118A1 7-Oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/16/1992	EP0517925A1 Novel megakaryocyte amplifier and production thereof
12/16/1992	EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME
12/16/1992	EP0517740A1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions.
12/16/1992	CN1019451B Cycioalkyliamides of (8beta)-1-alkyl-6-(substituted) ergolines
12/15/1992	US5171844 For use in treating hemophilia
12/15/1992	CA1311583C Peptide derivatives and their application, in particular in therapy
12/15/1992	CA1311483C 5-pyrazolylcarbonyl- and 5-pyrazolyvinyl-phenoxy acetic acid derivatives and processes for preparing the same
12/15/1992	CA1311481C 1,4-dihydropyridines, to their obtention processes and to their use asantithrombotic drugs
12/14/1992	CA2071145A1 Compounds and methods for treatment of thromboembolic disorders
12/13/1992	CA2070895A1 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/12/1992	CA2070796A1 Arylethers, their manufacture and methods of treatment
12/12/1992	CA2070795A1 Amidino compounds, their manufacture and methods of treatment
12/10/1992	WO1992021702A1 Specifically beta-beta cross-linked hemoglobins and method of preparation
12/10/1992	WO1992021402A1 Method for improving autologous transplantation
12/10/1992	WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/10/1992	CA2109699A1 Method for improving autologous transplantation
12/10/1992	CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/09/1992	EP0516980A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
12/09/1992	EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof
12/09/1992	EP0516792A1 Heparin derivatives
12/08/1992	US5169838 Benzopyranone-β-D-thioxylosides and their use in therapy
12/08/1992	US5169836 Inhibitors of platelet binding
12/02/1992	EP0515668A1 OXO-TETRAHYDROPYRIDAZINYL-PYRAZOLO 4,3-b]-1,4-BENZOXAZINES
12/02/1992	EP0515550A1 Heparin neutralization with platelet factor 4
12/02/1992	EP0515546A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515456A1 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them.
12/02/1992	EP0496833A4 Biosynthetic constructs of tgf--g(b)
12/02/1992	EP0357724B1 Stabilized heparin solution
12/02/1992	CN1066660A Peptide compound and process for preparation thereof
12/02/1992	CN1066653A Benzoheterocyclic compounds
12/01/1992	WO1992021755A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	WO1992021671A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	CA2108580A1 Treatment of hiv-associated immune thrombocytopenic purpura
12/01/1992	CA2102109A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1, 4-benzodioxine and the process of preparation thereof
11/1992
11/26/1992	WO1992020657A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
11/26/1992	WO1992020335A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
11/26/1992	WO1992017065A3 Method of inhibiting fibrosis
11/25/1992	EP0514917A1 Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514667A1 Benzazepin derivatives as vasopressin antagonists
11/25/1992	CN1019194B Preparation of bicyclic sulfonamide
11/24/1992	US5166416 Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them
11/24/1992	US5166377 Thromboxane A2 antagonist as coagulants or vasoconstrictors
11/24/1992	US5166347 Hypotensive agents, cardiovascular disorders, antiischemic agents and anticoagulants
11/24/1992	US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof
11/24/1992	US5166318 Anticoagulants
11/24/1992	US5166213 4-pyridyl substituted-1,3-dioxane compounds
11/24/1992	US5166161 Antiallergens or antiinflammatory agents
11/24/1992	US5166137 Guluronic acid polymers and use of same for inhibition of cytokine production
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/19/1992	EP0513997A1 Antithrombotic compositions
11/19/1992	EP0513783A2 Method for the removal of contaminants from perfluorinated alkyl bromides or alkylene dibromides
11/19/1992	EP0513778A2 Hybrid monoclonal antibodies and compositions containing them
11/19/1992	EP0513675A1 New peptide compound and a process for the preparation thereof
11/19/1992	EP0513543A1 Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them.
11/19/1992	EP0513533A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application
11/19/1992	EP0513150A1 New method for treating immunodeficiency or neutropenia
11/18/1992	CN1066292A Compounds, named "leustroducsins", their preparation and their therapeutic uses
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/17/1992	US5164503 Reduction, hydrolysis
11/17/1992	US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
11/17/1992	US5164401 Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane compounds
11/17/1992	US5164378 Supersulfated heparins
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/17/1992	US5164371 Inhibitors of human leukocytic elastase
11/15/1992	WO1992020708A1 Peptide inhibitors of inflammation
11/15/1992	CA2103139A1 Peptide inhibitors of inflammation
11/14/1992	CA2068478A1 Peptide compound and a process for the preparation thereof

1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 671